Suzhou Fengbei Biotech Stock Co., Ltd. Class A

Suzhou Fengbei Biotech Stock Co., Ltd. Class A

SSSE:603334
24.88
CNY
-0.14
(-0.56%)
0.93EPS
34.26P/E
4.56BMarket Cap
Suzhou Fengbei Biotech Stock Co., Ltd. Class A
SSE:603334
(Shanghai Stock Exchange)

Recent

price

24.88

P/E

ratio

34.26

div

yld

1.54%

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
CNY
- -
- -
- -
- -
- -
27.97
30.55
Revenue per Share
- -
- -
- -
- -
- -
1.24
0.93
Basic EPS, GAAP
- -
- -
- -
- -
- -
-0.45
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.09
0.38
Dividend per Share
- -
- -
- -
- -
- -
11.83
12.26
Book Value per Share
- -
- -
- -
- -
- -
11.39
11.46
Tangible Book Value per Share
- -
144
144
144
108
113
144
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
3,171
4,403
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
5.28
3.99
Operating Margin (%)
- -
- -
- -
- -
- -
31
- -
Depreciation Expense
- -
- -
- -
- -
- -
141
134
Net Income, GAAP
- -
- -
- -
- -
- -
8.45
11.21
Effective Tax Rate (%)
- -
- -
- -
- -
- -
4.43
3.04
Profit Margin (%)
194
- -
- -
- -
- -
1,235
1,208
Working Capital
- -
- -
- -
- -
- -
23
- -
LT Debt
- -
- -
- -
- -
- -
1,700
1,764
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
124
232
264
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
144
144
144
Market Capitalization
7,158
5,099
4,563

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,670
1,730
1,669
Cash, Cash Equivalents & STI
793
666
705
Accounts Receivable, Net
146
379
219
Inventories
454
473
512
Total Current Liabilities
414
499
462
Payables & Accruals
- -
- -
- -
ST Debt
124
232
264
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
666
812
- -
919
3,171
2026
1,109
1,238
1,137
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.34
0.34
- -
0.16
1.24
2026
0.28
0.28
0.2
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.02
0.02
- -
0.03
0.09
2026
0.01
0.33
0.01
- -
- -
Business
Suzhou Fengbei Biotech Stock Co., Ltd. (603334.SS) specializes in the comprehensive utilization of waste oil and fat resources to manufacture and sell resource-based products in China. The company produces bio-based materials serving as additives for pesticides, fertilizers, mineral processing, ink resins, textiles, and biopharmaceuticals; biofuels, primarily biodiesel; oleochemicals including methyl oleate, methylated soybean oil (excluding food products), DD oil, and fatty acids; and industrial packaging materials, with additional involvement in research, development, production, and sales of bio-organic fertilizers, compound microbial fertilizers, bio-pesticide technologies, and fertilizer production services. It operates as an independent import-export agent for commodities and technologies, providing technical services, development, consultation, exchange, transfer, and promotion, primarily from its headquarters at No. 1 Donghai Road, Yangtze River Chemical Industry Park, Zhangjiagang, Jiangsu Province, China, where it was founded in 2014 and employs approximately 360 people. In a major recent development, the company listed its shares on the Main Board of the Shanghai Stock Exchange on November 5, 2025, marking its transition to a publicly traded entity and enhancing its access to capital markets for expansion in the bio-based materials and biofuels sectors.